CMP Therapeutics Readies EU Launch With An Eye On The U.S.
By
Malcolm Spicer / Email the Author / “The Tan Sheet” Jan. 23, 2012, Vol. 20, No. 04
Business & Finance / Word Count: 1109 / Article # 05120116001
Executive Summary
CMP Therapeutics talks with large and small pharmas about distributing its micronized nasal spray, branded as Atlantic Secret. EU regulatory approval came seven years after the firm’s launch, but CEO Neil Moray Mackenzie expects much less time before a U.S. launch.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.